首页> 外文期刊>Cancer biology & therapy >Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene.
【24h】

Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene.

机译:溶瘤腺病毒武装的靶向hTERT基因的短发夹RNA抑制肾癌细胞的生长。

获取原文
获取原文并翻译 | 示例
           

摘要

RNA interference (RNAi) has been proved to be a powerful tool for gene knockdown purpose and holds a great promise for the treatment of cancer. Our previous study demonstrated that the reduction of hTERT expression by means of chemically synthesized siRNAs and shRNAs expressed from plasmid resulted in proliferation inhibition in human renal carcinoma cells. In this study, we constructed a novel oncolytic adenovirus-based shRNA expression system, ZD55-hTERT, and to explore ZD55-hTERT-mediated RNAi for hTERT gene silencing. Our results showed that ZD55-hTERT could induce silencing of hTERT gene effectively, allow for efficient tumor-specific viral replication and induce the apoptosis of tumor cells effectively in vitro and in nude mice. We conclude that combining shRNA gene therapy and oncolytic virotherapy can enhance antitumor efficacy as a result of synergism between CRAd oncolysis and shRNA antitumor responses.
机译:RNA干扰(RNAi)已被证明是用于基因敲除目的的强大工具,在治疗癌症方面具有广阔的前景。我们先前的研究表明,通过化学合成的从质粒表达的siRNA和shRNA减少hTERT的表达可导致人肾癌细胞的增殖抑制。在这项研究中,我们构建了一个基于溶瘤腺病毒的新型shRNA表达系统ZD55-hTERT,并探索了ZD55-hTERT介导的RNAi用于hTERT基因沉默。我们的结果表明,ZD55-hTERT可以有效诱导hTERT基因沉默,实现有效的肿瘤特异性病毒复制,并在体外和裸鼠中有效诱导肿瘤细胞的凋亡。我们得出结论,由于CRAd溶瘤作用与shRNA抗肿瘤反应之间的协同作用,shRNA基因治疗与溶瘤病毒治疗相结合可以增强抗肿瘤功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号